12 Health Care Stocks Moving In Tuesday's Intraday Session
Portfolio Pulse from Benzinga Insights
Healthcare stocks experienced significant movements in Tuesday's intraday session. Stoke Therapeutics (STOK) led the gainers with a 71.8% increase following their Q4 earnings report. Other notable gainers include Mesoblast (MESO), OpGen (OPGN), Alpha Teknova (TKNO), Nuvation Bio (NUVB), and Journey Medical (DERM). On the losing side, NeuBase Therapeutics (NBSE) saw the largest decline of 51.8%. Other decliners were Prenetics Global (PRE), Equillium (EQ), SCWorx (WORX), Monte Rosa Therapeutics (GLUE), and Biodexa Pharmaceuticals (BDRX).
March 26, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
NeuBase Therapeutics experienced the largest decline among healthcare stocks, dropping 51.8% during Tuesday's session.
NBSE's significant stock price decline is notable among healthcare stocks, reflecting negative market sentiment.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Stoke Therapeutics saw a significant rise of 71.8% in its stock price following the release of its Q4 earnings.
The substantial increase in STOK's stock price is directly attributed to its Q4 earnings report, indicating positive investor response.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90